Pharmaceutical Product Supply – Rho(D) Immune Globulin

The contract seeks the supply of Rho(D) Immune Globulin, USP, 300 mcg in 1 mL disposable syringes equipped with safety features for intramuscular injection, to be delivered FOB Destination to a U.S. Navy vessel. The product must meet stringent pharmaceutical standards and be packaged in a manner that ensures safety, sterility, and compliance with regulatory requirements for use in military medical settings. The delivery location is designated as FPO with a ZIP code of 96666, indicating shipment to a naval vessel operating in a mobile or overseas theater, requiring precise logistical coordination and adherence to military procurement protocols. This is a subcontract under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing, and is administered by the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 29, 2026, with responses required by August 4, 2026, suggesting a time-sensitive procurement intended to maintain operational readiness. The use of FOB Destination terms places responsibility for delivery and associated risks on the contractor until the product reaches the vessel, ensuring the military receives goods in optimal condition. The requirement for safety-engineered syringes reflects a commitment to minimizing occupational exposure and enhancing clinical safety for medical personnel aboard the vessel.